TORSELLO, ANTONIO BIAGIO
TORSELLO, ANTONIO BIAGIO
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Cannabinoid Receptor 2 (CB2R) as potential target for the pharmacological treatment of neurodegenerative diseases
2025 Meanti, R; Bresciani, E; Rizzi, L; Molteni, L; Coco, S; Omeljaniuk, R; Torsello, A
Ghrelin, Neuroinflammation, Oxidative Stress, and Mood Disorders: What Are the Connections?
2025 Mingardi, J; Meanti, R; Paoli, C; Cifani, C; Torsello, A; Popoli, M; Musazzi, L
Influence of efavirenz and 8-hydroxy-efavirenz plasma levels on cognition and central nervous system side effects
2024 Ranzani, A; Castelli, F; Di Biagio, A; d'Arminio Monforte, A; D'Avolio, A; Soria, A; Bai, F; Focà, E; Taramasso, L; Calcagno, A; Bresciani, E; Torsello, A; Bonfanti, P; Lapadula, G
Potential application of Growth Hormone Secretagogues (GHS) for Amyotrophic Lateral Sclerosis (ALS) treatment: mechanisms of action and neuroprotective effects characterization in human SH-SY5Y SOD1G93A cells
2024 Meanti, R; Rizzi, L; Bresciani, E; Licata, M; Molteni, L; Omeljaniuk, R; Fehrentz, J; Denoyelle, S; Locatelli, V; Torsello, A
Selected Growth Hormone Secretagogues (GHS) as disease modifiers in an in vitro model of Amyotrophic Lateral Sclerosis: a proof-of-concept study
2024 Meanti, R; Rizzi, L; Bresciani, E; Licata, M; Molteni, L; Omeljaniuk, R; Fehrentz, J; Denoyelle, S; Locatelli, V; Torsello, A
Selected Growth Hormone Secretagogues (GHS) as promising therapeutical approach for Amyotrophic Lateral Sclerosis: a proof-of-concept study
2024 Meanti, R; Rizzi, L; Bresciani, E; Licata, M; Sartori, E; Omeljaniuk, R; Fehrentz, J; Denoyelle, S; Locatelli, V; Torsello, A
Conditioned Medium of Mesenchymal Stromal Cells Loaded with Paclitaxel Is Effective in Preclinical Models of Triple-Negative Breast Cancer (TNBC)
2023 Cordani, N; Lisini, D; Cocce, V; Paglia, G; Meanti, R; Cerrito, M; Tettamanti, P; Bonaffini, L; Paino, F; Alessandri, G; Marcianti, A; Gianni, A; Villa, C; Mauri, M; Mologni, L; Torsello, A; Pessina, A; Cazzaniga, M
Development of Growth Hormone Secretagogues as new therapeutical tools for Amyotrophic Lateral Sclerosis
2023 Meanti, R; Rizzi, L; Bresciani, E; Molteni, L; Locatelli, V; Torsello, A
Growth hormone secretagogues modulate inflammation and fibrosis in mdx mouse model of Duchenne muscular dystrophy
2023 Boccanegra, B; Cappellari, O; Mantuano, P; Trisciuzzi, D; Mele, A; Tulimiero, L; De Bellis, M; Cirmi, S; Sanarica, F; Cerchiara, A; Conte, E; Meanti, R; Rizzi, L; Bresciani, E; Denoyelle, S; Fehrentz, J; Cruciani, G; Nicolotti, O; Liantonio, A; Torsello, A; De Luca, A
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis
2023 Meanti, R; Bresciani, E; Rizzi, L; Coco, S; Zambelli, V; Dimitroulas, A; Molteni, L; Omeljaniuk, R; Locatelli, V; Torsello, A
Prokineticin 2 and Cytokine Content in the Synovial Fluid of Knee Osteoarthritis and Traumatic Meniscal Tear Patients: Preliminary Results
2023 Turati, M; Franchi, S; Crippa, M; Rizzi, L; Rigamonti, L; Sacerdote, P; Gatti, S; Piatti, M; Galimberti, G; Munegato, D; Amodeo, G; Omeljaniuk, R; Zatti, G; Torsello, A; Bigoni, M
Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein
2023 Meanti, R; Licata, M; Rizzi, L; Bresciani, E; Molteni, L; Coco, S; Locatelli, V; Omeljaniuk, R; Torsello, A
Characterization of microRNA Levels in Synovial Fluid from Knee Osteoarthritis and Anterior Cruciate Ligament Tears
2022 Rizzi, L; Turati, M; Bresciani, E; Anghilieri, F; Meanti, R; Molteni, L; Piatti, M; Zanchi, N; Coco, S; Buonanotte, F; Rigamonti, L; Zatti, G; Locatelli, V; Omeljaniuk, R; Bigoni, M; Torsello, A
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis
2022 Bresciani, E; Squillace, N; Orsini, V; Piolini, R; Rizzi, L; Molteni, L; Meanti, R; Soria, A; Lapadula, G; Bandera, A; Gori, A; Bonfanti, P; Omeljaniuk, R; Locatelli, V; Torsello, A
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis: the case of hexarelin and JMV2894
2022 Meanti, R; Rizzi, L; Bresciani, E; Molteni, L; Locatelli, V; Torsello, A
Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis
2022 Meanti, R; Rizzi, L; Bresciani, E; Licata, M; Molteni, L; Locatelli, V; Torsello, A
Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis
2022 Meanti, R; Rizzi, L; Bresciani, E; Licata, M; Molteni, L; Locatelli, V; Torsello, A
Association between renin-angiotensin-aldosterone system inhibitors and risk of dementia: A meta-analysis
2021 Scotti, L; Bassi, L; Soranna, D; Verde, F; Silani, V; Torsello, A; Parati, G; Zambon, A
Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury
2021 Zambelli, V; Rizzi, L; Delvecchio, P; Bresciani, E; Rezoagli, E; Molteni, L; Meanti, R; Cuttin, M; Bovo, G; Coco, S; Omeljaniuk, R; Locatelli, V; Bellani, G; Torsello, A
Hexarelin modulation of mapk and pi3k/akt pathways in neuro-2a cells inhibits hydrogen peroxide-induced apoptotic toxicity
2021 Meanti, R; Rizzi, L; Bresciani, E; Molteni, L; Locatelli, V; Coco, S; Omeljaniuk, R; Torsello, A